In this context, GLP-1 microbiome support is best understood as a systems-based approach that connects gut barrier resilience, Akkermansia activity, microbial balance, and digestive adaptation during GLP-1 therapy
Cell Metab 26:620632
10.1186/s12986-017-0217-z Summary Keywords GLP-1, incretin mimetics, neurodegeneration, Parkinsons disease, phytoconstituents, sirtuins, -synuclein Citation Juthi SS, Ansari P, Ahmed MF, Khan JT, Seidel V, Kumar S, Kumari R, McKillop A, Abdel-Wahab YHA and Flatt PR (2026) Molecular mechanisms underlying Parkinsons disease and role of phytochemicals, -synuclein, sirtuins, and incretin mimetics in potential therapy
(Peptide Sciences) Resulting effects Selective apoptosis of senescent cells reduced senescent cell burden
Lower risk generally supports greater long-term sustainability